90 related articles for article (PubMed ID: 19660835)
1. Altered phosphorylation but no neurodegeneration in a mouse model of tau hyperphosphorylation.
Hundelt M; Fath T; Selle K; Oesterwind K; Jordan J; Schultz C; Götz J; von Engelhardt J; Monyer H; Lewejohann L; Sachser N; Bakota L; Brandt R
Neurobiol Aging; 2011 Jun; 32(6):991-1006. PubMed ID: 19660835
[TBL] [Abstract][Full Text] [Related]
2. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
Zhang Q; Zhang X; Sun A
Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
[TBL] [Abstract][Full Text] [Related]
3. Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration.
Kulic L; Wollmer MA; Rhein V; Pagani L; Kuehnle K; Cattepoel S; Tracy J; Eckert A; Nitsch RM
Neurobiol Aging; 2011 Oct; 32(10):1827-38. PubMed ID: 19942317
[TBL] [Abstract][Full Text] [Related]
4. Inverse and distinct modulation of tau-dependent neurodegeneration by presenilin 1 and amyloid-beta in cultured cortical neurons: evidence that tau phosphorylation is the limiting factor in amyloid-beta-induced cell death.
Leschik J; Welzel A; Weissmann C; Eckert A; Brandt R
J Neurochem; 2007 Jun; 101(5):1303-15. PubMed ID: 17298384
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.
Schindowski K; Bretteville A; Leroy K; Bégard S; Brion JP; Hamdane M; Buée L
Am J Pathol; 2006 Aug; 169(2):599-616. PubMed ID: 16877359
[TBL] [Abstract][Full Text] [Related]
6. Transgenic zebrafish model of neurodegeneration.
Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG
J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595
[TBL] [Abstract][Full Text] [Related]
7. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice.
Lucas JJ; Hernández F; Gómez-Ramos P; Morán MA; Hen R; Avila J
EMBO J; 2001 Jan; 20(1-2):27-39. PubMed ID: 11226152
[TBL] [Abstract][Full Text] [Related]
8. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
9. FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain.
Lim F; Hernández F; Lucas JJ; Gómez-Ramos P; Morán MA; Avila J
Mol Cell Neurosci; 2001 Dec; 18(6):702-14. PubMed ID: 11749044
[TBL] [Abstract][Full Text] [Related]
10. Change in tau phosphorylation associated with neurodegeneration in the ME7 model of prion disease.
Asuni AA; Perry VH; O'Connor V
Biochem Soc Trans; 2010 Apr; 38(2):545-51. PubMed ID: 20298219
[TBL] [Abstract][Full Text] [Related]
11. Differential regional distribution of phosphorylated tau and synapse loss in the nucleus accumbens in tauopathy model mice.
Kambe T; Motoi Y; Inoue R; Kojima N; Tada N; Kimura T; Sahara N; Yamashita S; Mizoroki T; Takashima A; Shimada K; Ishiguro K; Mizuma H; Onoe H; Mizuno Y; Hattori N
Neurobiol Dis; 2011 Jun; 42(3):404-14. PubMed ID: 21324362
[TBL] [Abstract][Full Text] [Related]
12. Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration.
Hébert SS; Papadopoulou AS; Smith P; Galas MC; Planel E; Silahtaroglu AN; Sergeant N; Buée L; De Strooper B
Hum Mol Genet; 2010 Oct; 19(20):3959-69. PubMed ID: 20660113
[TBL] [Abstract][Full Text] [Related]
13. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles.
Wittmann CW; Wszolek MF; Shulman JM; Salvaterra PM; Lewis J; Hutton M; Feany MB
Science; 2001 Jul; 293(5530):711-4. PubMed ID: 11408621
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of mouse model exhibiting neurofibrillary changes].
Takashima A
Rinsho Shinkeigaku; 2001 Dec; 41(12):1111-2. PubMed ID: 12235811
[TBL] [Abstract][Full Text] [Related]
15. Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau.
Tatebayashi Y; Miyasaka T; Chui DH; Akagi T; Mishima K; Iwasaki K; Fujiwara M; Tanemura K; Murayama M; Ishiguro K; Planel E; Sato S; Hashikawa T; Takashima A
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13896-901. PubMed ID: 12368474
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation differentiates tau-dependent neuronal toxicity and dysfunction.
Papanikolopoulou K; Kosmidis S; Grammenoudi S; Skoulakis EM
Biochem Soc Trans; 2010 Aug; 38(4):981-7. PubMed ID: 20658989
[TBL] [Abstract][Full Text] [Related]
17. The pattern of human tau phosphorylation is the result of priming and feedback events in primary hippocampal neurons.
Bertrand J; Plouffe V; Sénéchal P; Leclerc N
Neuroscience; 2010 Jun; 168(2):323-34. PubMed ID: 20394726
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation.
Pérez M; Ribe E; Rubio A; Lim F; Morán MA; Ramos PG; Ferrer I; Isla MT; Avila J
Neuroscience; 2005; 130(2):339-47. PubMed ID: 15664690
[TBL] [Abstract][Full Text] [Related]
19. Beta-amyloid overload does not directly correlate with SAPK/JNK activation and tau protein phosphorylation in the cerebellar cortex of Ts65Dn mice.
Lomoio S; Scherini E; Necchi D
Brain Res; 2009 Nov; 1297():198-206. PubMed ID: 19703431
[TBL] [Abstract][Full Text] [Related]
20. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
